TY  - CHAP
M1  - Book, Section
TI  - Ovarian Cancer
A1  - Smith, Judith A.
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
Y1  - 2022
N1  - 
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Demonstrate  understanding  of  the  etiology  and  risk  factors  associated  with  the  development  of  ovarian  cancer.Justify  the  risk  and  benefits  of  the  surgical  and  chemoprevention  options  available  for  decreasing  the  potential  risk  of  developing  ovarian  cancer.Interpret  and  understand  the  utility  of  the  screening  tests  and  serologic  markers  for  diagnosing  ovarian  cancer.Distinguish  the  nonspecific  physical  signs  and  symptoms  of  ovarian  cancer.Recommend  the  appropriate  surgical  and  chemotherapy  treatment  options  for  newly  diagnosed,  persistent,  and  recurrent  ovarian  cancer  patients.Discuss  the  role  of  first-line  maintenance  treatment  for  improving  overall  survival  for  ovarian  cancer  patients.Compare  and  contrast  chemotherapy  options  for  women  with  recurrent  platinum-resistant  ovarian  cancer.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/06
UR  - ppp.mhmedical.com/content.aspx?aid=1187022745
ER  -